| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8682016 | Clinical Neurology and Neurosurgery | 2018 | 16 Pages |
Abstract
Our findings suggest that GPR65 is overexpressed in glioblastoma and its high expression predicts unfavorable clinical outcome for patients. Targeting GPR65 may serve as a potential therapy for treating glioblastoma.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Hong-Xiang Wang, Yi-Hong Chen, Jin-Xu Zhou, Xin-Yu Hu, Cong Tan, Yong Yan, Qi-Lin Huang, Jun-Yan Shen, Han-Chong Xu, Feng Li, Zhen-Yu Gong, Tao Xu, Ju-Xiang Chen,